Washington — The House passed a massive spending and tax bill that includes signature policies of President Trump’s second-term agenda Thursday, sending the so-called “big, beautiful bill” to the president’s desk ahead of a July 4 deadline. The House approved the bill in a 218 to 214 vote Thursday, after the Senate narrowly approved the bill
Washington — The House on Thursday passed the signature piece of legislation of President Trump’s second term, approving a massive bill that includes trillions of dollars in tax and spending cuts while ramping up funding for defense and the administration’s immigration agenda. The lower chamber voted 218 to 214 to approve the measure, with two
A Tennessee man pardoned by President Trump in January for his role in the Jan. 6, 2021, assault on the U.S. Capitol will nevertheless serve a life sentence for plotting to attack FBI agents and seeking to incite a “civil war,” according to prosecutors. Edward Kelley, who was the fourth U.S. Capitol rioter to enter
Washington — The House is voting Thursday on President Trump’s “big, beautiful bill” after Republican leaders overcame resistance from GOP holdouts in a dramatic overnight session, prompting Democratic Leader Hakeem Jeffries to delay a final vote by delivering the longest House speech on record. “We’ll have the votes,” House Speaker Mike Johnson said in the morning. “We’ll land
Washington — The House is nearing a final vote Thursday on President Trump’s “big, beautiful bill” after Republican leaders overcame resistance from GOP holdouts in a dramatic overnight session, prompting Democratic Leader Hakeem Jeffries to delay a final vote by delivering the longest House speech on record. “We’ll have the votes,” House Speaker Mike Johnson said Thursday morning.
Top-ranking Food and Drug Administration officials picked by the Trump administration under Health and Human Services Secretary Robert F. Kennedy Jr. overrode career staff at the agency to limit the approvals of COVID-19 shots from Novavax and Moderna, according to records released by the FDA. In a memorandum following Novavax’s approval in May, which narrowed
The Department of Homeland Security’s intelligence arm plans to cut nearly three-quarters of its full-time employees, shaving its Office of Intelligence & Analysis down from about 1,000 staff to just 275, according to four sources briefed on the matter. The exact timing of the cuts remains unclear; sources tell CBS News the staff reductions have